| Ranbaxy Laboratories (BSE: 500359 | NSE: RANBAXY | ISIN: INE015A01028) |
 |
481.25  14.55 (3.12%) |
| BSE : Jul 25, 16:01 |
|
| 481.10 14.05 (3.01%) |
| NSE : Jul 25, 15:58 |
|
| Open |
459.70 |
Vol |
1,264,626 |
| Prev. Close |
466.70 |
|
|
|
Intraday |
52 Week |
|
| Highs |
485.90 |
613.70 |
|
| Lows |
450.00 |
299.90 |
|
|
| Open |
460.00 |
Vol |
2,569,368 |
| Prev. Close |
467.05 |
|
|
|
Intraday |
52 Week |
|
| Highs |
485.85 |
660.00 |
|
| Lows |
442.25 |
297.05 |
|
|
|
BID |
OFFER |
| Price |
481.25 |
482.80 |
| Quantity |
261.00 |
50.00 |
|
|
BID |
OFFER |
| Price |
0.00 |
481.10 |
| Quantity |
0.00 |
1,208.00 |
|
| Mkt Cap |
17,962.07 |
| |
* P/E |
29.39 |
| |
Div |
170.00 |
| |
* EPS (TTM) |
16.37 |
| |
B/V: |
67.98 |
| Mkt Lot |
1.00 |
| |
FV |
5.00 |
| |
* EPS: As per stand alone adjusted profit after extra-ordinary items |
|
| Historic Prices & Returns of Ranbaxy Labs |
Compare Price Performance With Peers |
| Price |
1 week |
2 week |
1 month |
3 month |
6 month |
9 month |
1 year |
| BSE |
/ |
NSE |
| 452.20 |
537.00 |
525.30 |
475.30 |
346.80 |
429.10 |
344.55 |
| 6.42% |
-10.38% |
-8.39% |
1.25% |
38.77% |
12.15% |
39.67% |
| 452.50 |
536.85 |
525.20 |
474.85 |
348.10 |
428.75 |
344.80 |
| 6.32% |
-10.38% |
-8.4% |
1.32% |
38.21% |
12.21% |
39.53% |
|
Gain/Loss |
|
|
|
| This page Auto Refreshes every 5 minutes |
|
|
|
| |
|
|
|
|
|
| BSE/NSE Notices - Ranbaxy Labs |
| Ranbaxy Laboratories Ltd has informed BSE regarding a Press Release dated July 23, 2008 titled "Ranbaxy launches Generic Amlodipine Tablets on Day-1 i |
| |
| more... |
| |
|
|
|
| Financials of Ranbaxy Labs |
Quarterly |
Annual
|
| Income Statement |
(Mar '08) |
(Dec '07) |
| Net Sales |
987.29 |
4293.02 |
| Other Income |
87.68 |
551.13 |
| PBDIT |
100.28 |
965.72 |
| Net Profit |
103.42 |
617.72 |
|
|
|
| Balance Sheet |
| Total Share Capital |
186.54 |
| Net Worth |
2538.40 |
| Total Debt |
3503.03 |
| Net Block |
1469.52 |
| Investments |
3237.55 |
| Net Current Assets |
1006.93 |
| Total Assets |
6041.42 |
|
|
|
|
|
|
|
|
|
| Company Facts - Ranbaxy Labs |
|
|
|
| Registrars |
Alankit Assignment Ltd.
2E/8, Blazeflash House,
R T A Division, 1st Floor
Jhandewalan Extension,
|
| Tel : 51540060, 51540061, 51540062, 51540063 |
| Fax : 51540064 |
| Email : nahar@alankit.com |
Website :
|
|
|
|
|
|
| Management - Ranbaxy Labs |
| |
| Harpal Singh Non Executive Chairman |
| Vivek Bharat Ram Director |
| Gurcharan Das Director |
| Sunil Godhwani Director |
| P S Joshi Director |
| Nimesh N Kampani Director |
| V K Kaul Director |
| Vivek Mehra Director |
| Ravi Mehrotra Director |
| Shivinder Mohan Singh Director |
| Surendra Daulet-Singh Director |
| Brian W Tempest Non Executive Director |
| Malvinder Mohan Singh Managing Director & CEO |
| Atul Sobti Whole Time Director & COO |
| Ramesh L Adige Whole Time Director |
| |
|
|
Offline
